25.49 USD
↗ 0.07 (0.30%)PRE MARKET (AS OF 09:10 AM EDT)
PFE is currently priced at $25.49. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". Notable factors include a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Aug 4, 2026.
Open?$25.33
High?$25.51
Low?$25.32
Prev. Close?$25.41
Volume?720.7K
Avg. Volume?46.0M
VWAP?$25.46
Rel. Volume?0.02x
Bid / Ask
Bid?$25.46 × 100
Ask?$25.47 × 400
Spread?$0.01
Midpoint?$25.47
Valuation & Ratios
Market Cap?144.8B
Shares Out?5.7B
Float?4.8B
Float %?84.9%
P/E Ratio?33.43
P/B Ratio?1.70
EPS?$0.76
Dividend?6.76%
Ex-Dividend?N/A
News
Profile
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Employees
75.0K
Market Cap
142.7B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1951-06-22
Address
66 HUDSON BOULEVARD EAST
NEW YORK, NY 10001-2192
Phone: (212) 733-2323
NEW YORK, NY 10001-2192
Phone: (212) 733-2323
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?40
Momentum?60
Short Sent.?69
Piotroski F-Score?3/9Weak
Altman Z-Score?2.12Grey
Confidence?71%Moderate
Short InterestModerate
Short % of Float?3.38%Low
Short Interest?163.8M
Days to Cover?3.8
Free Float4.8B
Avg Daily Volume42.8M
Settlement Date2026-07-15
Financial Health
Current Ratio?1.27Adequate
Quick Ratio?0.96Weak
Cash Ratio?0.03Low
Debt/Equity?0.74Moderate
ValuationATTRACTIVELY VALUEDvs 10 peers + S&P 500
Score83/100
P/E?33.4PRICEY▾
Peers56
S&P26
P/B?1.70CHEAP▾
Peers100
S&P82
P/S?2.27CHEAP▾
Peers91
S&P61
P/FCF?13.2CHEAP▾
Peers88
S&P80
EV/EBITDA?8.8CHEAP▾
Peers100
S&P87
EV/Sales?3.25FAIR▾
Peers91
S&P57
Returns & Efficiency
ROE?5.1%FAIR▾
Peers11
S&P19
ROA?2.2%WEAK▾
Peers11
S&P21
Cash Flow & Enterprise
FCF?$11.0B
Enterprise Value?$207.0B
Fundamentals ratios updated end of day